Better, faster and more accessible healthcare, enabling world-class leadership teams to succeed on the global stage.
Global Healthcare Opportunities

Better, Faster + More Accessible HealthcareTM

Find out how

Europe's leading specialist investor in healthcare, applying global capabilities and perspectives to unlock high growth healthcare opportunities

In a Nutshell

€0bn
AUM (~)
10%
Target Annual Returns
60+
Completed Transactions
190+
Global portfolio locations
36
Team Members
2
Team Nationalities

Specialist Investor

Differentiated Approach

We support quality-focused companies to meet the global demand for better healthcare outcomes. Our team has deep experience in originating, evaluating and realising opportunities in complex healthcare subsectors.
What we do +    Our Team

Enabling world-class leadership teams to succeed on the global stage

Visit our portfolio
Map Background
Map Background
Company: Envision Pharma Group
Map Background
Company: Sterling Pharma Solutions
Map Background
Company: Validant
Map Background
Company: Ardena
Map Background
Company: Genesis Research

News + Updates

GHO Capital Updates

GHO Capital Appoints Jim Datin, former President and CEO of BioAgilityx, as Operating Partner

+Read Update
Sterling Pharma Solutions

Sterling Pharma Solutions Completes Acquisition of API Manufacturing Facility in Ringaskiddy, Ireland

+Read Update
Velocity Clinical Research

Velocity Clinical Research acquires Meridian Clinical Research creating largest global research sites business

+Read Update
Sapio Sciences

GHO Capital invests in Sapio Sciences, a leading, high growth lab informatics platform company

+Read Update
Biocare Medical

Biocare Medical Acquires Empire Genomics, Expanding Molecular Portfolio to over 1 Million Biomarkers and Adding Rapid Biomarker Development to Lead Cancer Research

+Read Update
Alcami

GHO Capital and The Vistria Group to acquire Alcami, a leading high growth CDMO, from Madison Dearborn Partners and Ampersand Capital Partners

+Read Update
GHO Capital Updates

GHO Capital Appoints Alistair Macdonald as Operating Partner

+Read Update
RoslinCT

RoslinCT and Lykan Bioscience Combine to Create Leading Advanced Cell Therapy CDMO

+Read Update